Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes.

Cortina S, Repaske DR, Hood KK.

Pediatr Diabetes. 2010 Aug;11(5):337-44. doi: 10.1111/j.1399-5448.2009.00593.x.

PMID:
19761529
2.
3.
4.
5.

Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada.

St Charles ME, Sadri H, Minshall ME, Tunis SL.

Clin Ther. 2009 Mar;31(3):657-67. doi: 10.1016/j.clinthera.2009.03.013.

PMID:
19393856
6.

[Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes].

Nørgaard K, Sohlberg A, Goodall G.

Ugeskr Laeger. 2010 Jul 5;172(27):2020-5. Danish.

PMID:
20594535
8.

Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.

Opipari-Arrigan L, Fredericks EM, Burkhart N, Dale L, Hodge M, Foster C.

Pediatr Diabetes. 2007 Dec;8(6):377-83.

PMID:
18036064
9.

Effects of insulin therapy with continuous subcutaneous insulin infusion (CSII) in diabetic patients: comparison with multi-daily insulin injections therapy (MDI).

Derosa G, Maffioli P, D'Angelo A, Salvadeo SA, Ferrari I, Fogari E, Mereu R, Gravina A, Palumbo I, Randazzo S, Cicero AF.

Endocr J. 2009;56(4):571-8.

10.

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

Diabetes Care. 2004 Jul;27(7):1554-8.

PMID:
15220227
11.

Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes.

Olinder AL, Kernell A, Smide B.

Pediatr Diabetes. 2009 Apr;10(2):142-8. doi: 10.1111/j.1399-5448.2008.00462.x.

PMID:
19175898
12.

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.

Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group..

Diabet Med. 2006 Feb;23(2):141-7.

PMID:
16433711
13.

A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.

Weinzimer SA, Ternand C, Howard C, Chang CT, Becker DJ, Laffel LM; Insulin Aspart Pediatric Pump Study Group..

Diabetes Care. 2008 Feb;31(2):210-5.

PMID:
17989308
14.

Continuous subcutaneous insulin infusion therapy: effects on quality of life.

Scheidegger U, Allemann S, Scheidegger K, Diem P.

Swiss Med Wkly. 2007 Aug 25;137(33-34):476-82.

PMID:
17990132
15.

Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.

Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J.

Pediatr Diabetes. 2008 Oct;9(5):472-9. doi: 10.1111/j.1399-5448.2008.00390.x.

PMID:
18721168
16.

Psychological aspects in continuous subcutaneous insulin infusion: a retrospective study.

Aberle I, Scholz U, Bach-Kliegel B, Fischer C, Gorny M, Langer K, Kliegel M.

J Psychol. 2009 Mar;143(2):147-60. doi: 10.3200/JRLP.143.2.147-160.

PMID:
19306678
17.

Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.

Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, Vogel C, Rosenbauer J, Holl RW; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy..

Diabet Med. 2008 Jan;25(1):80-5. doi: 10.1111/j.1464-5491.2007.02311.x.

PMID:
18199134
18.

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N.

Health Technol Assess. 2004 Oct;8(43):iii, 1-171. Review.

19.

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.

Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M.

Pediatrics. 2003 Sep;112(3 Pt 1):559-64.

PMID:
12949284
20.

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.

Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, Palmer AJ.

Pharmacoeconomics. 2007;25(10):881-97.

PMID:
17887808

Supplemental Content

Support Center